Main SCVS Site
Annual Meeting Home
Final Program
Past & Future Meetings
 

Back to 2016 Karmody Posters


Infrainguinal endovascular intervention in functionally dependent patients
Muhammad H. Zubair, MD, Sophia G. Afridi, MD, Timothy J. Fuller, MD, Patrick E. Muck, MD.
TriHealth - Good Samaritan Hospital, Cincinnati, OH, USA.

OBJECTIVE: Majority of patients who undergo infraingunal intervention for critical limb ischemia (CLI) are functionally dependent. Patients with functional dependence tend to fare worse with open infrainguinal bypasses. Few studies have evaluated the post endovascular outcomes in patients with CLI. Considering the minimally invasive nature of endovascular therapy and the predictable decrease in surgical morbidity, we evaluated the outcomes of functionally dependent patients with endovascular treatment of lower limb CLI.
METHODS: Patients undergoing endovascular infraingunal intervention were identified from American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database from 2005 to 2010. Demographics and outcome variables, including mortality, graft patency and need for amputation within 30 days, were compared between functionally dependent and independent patients. The Comprehensive Risk Assessment for Bypass (CRAB) score was calculated using NSQIP variables.
RESULTS: A total of 1,368 patients were included for analysis, of which 170 (12.4%) were funtionally dependent (Table 1). Patients with functional dependence had significantly higher CRAB score (11.7 ± 4.3 vs 3.67 ± 3.3; p<0.0001). Mortality within 30 days (8.8% vs 2.3%; p<0.0001) and major amputation (5.9% vs 0.6%; p<0.0001) were significantly greater for functionally dependent patients. A higher but not significant failure of intervention (3.5% vs 2.5%; p=0.4), deep surgical site infections (4.1% vs 0.8%; p=0.003), pneumonia (5.9% vs 1.8%; p=0.003), deep vein thrombosis (2.9% vs 0.5%; p=0.007), prolonged mechanical ventilation (9.4% vs 2.6%; p<0.00001), urinary tract infection (6.5% vs 1.5%; p<0.00001), sepsis (13.5% vs 2.8%; p<0.00001), and septic shock (5.3% vs 1.1%; p=0.001) was observed in patients with functional dependence.
CONCLUSIONS: Preoperative functional dependence should be given consideration while making decisions for infrainguinal lower limb interventions. A higher preop CRAB score is associated with functional dependence and may help in making this distinction in future prospective studies.
Table 1: Demographics and perioperative variablesTotal n=1366Independent n=1196Dependent n=170p
Age, mean (SD) years69.38 (10.9)69.16 (10.8)71.01 (11.5)0.04
CRAB score, mean (SD)4.67 (4.4)3.67 (3.3)11.7 (4.3)<0.00001
BMI, mean (SD)26.99 (6.78)27.17 (6.89)25.69 (5.81)0.009
Length of total hospital stay, mean (SD) days6.39 (11.7)5.23 (8.9)14.54 (21.7)<0.00001
Pre-operative serum creatinine, mean (SD) mg/dl1.37 (1.3)1.33 (1.2)1.66 (1.8)0.003
Pre-operative serum albumin, mean (SD) mg/dl3.62 (0.6)3.73 (0.5)3.13 (0.7)<0.00001
Pre-operative WBC, mean (SD) 1000cells/ul8.34 (3.4)8.10 (3.1)10.01 (4.8)<0.00001
Pre-operative hematocrit, mean (SD) 1000cells/ul37.98 (5.8)38.54 (5.5)34.01 (6.4)<0.00001
Pre-operative platelet count, mean (SD) 1000cells/ul242.07 (89.59)239.67 (83.5)258.75 (122.6)0.01
Pre-operative PTT, mean (SD) seconds34.83 (14.27)34.04 (13)40.03 (19.6)<0.00001
Pre-operative INR, mean (SD)1.13 (0.3)1.12 (0.3)1.25 (0.4)<0.00001
Number of RBC units given intraoperative, mean (SD)0.5 (1.2)0.44 (1.1)0.9 (1.7)<0.00001
Male, n (%)463 (33.9)385 (32.2)78 (45.9)0.002
White, n (%)1069 (78.3)945 (79)124 (72.9)0.07
Diabetes, n (%)382 (28)318 (26.5)160 (37.6)<0.00001
Current smoker, n (%)554 (40.6)491 (41.1)63 (37.1)0.3
EtOH > 2 drinks/day 2 wk before admission, n (%)85 (6.2)76 (6.4)9 (5.3)0.7
Dyspnea, n (%)298 (21.8)241 (20.2)57 (33.2)<0.00001
Ventilator dependent, n (%)17 (1.2)4 (0.3)13 (7.6)<0.00001
COPD, n (%)239 (17.5)199 (16.6)40 (23.5)0.03
Current Pneumonia, n (%)4 (0.3)1 (0.1)3 (1.8)0.007
Congestive heart failure, n (%)37 (2.7)23 (1.9)14 (8.2)<0.00001
Hypertension, n (%)1150 (84.2)1008 (84.3)142 (83.5)0.8
Acute Renal failure, n (%)18 (1.3)10 (0.8)8 (4.7)0.001
Impaired sensorium, n (%)17 (1.2)4 (0.3)13 (7.6)<0.00001
Hemiplegia, n (%)34 (2.5)19 (1.6)15 (8.8)<0.00001
History of TIA, n (%)84 (6.1)79 (6.6)5 (2.9)0.06
CVA/Stroke with defecit, n (%)91 (6.7)61 (5.1)30 (17.6)<0.00001
CVA/Stroke with no defecit, n (%)92 (6.7)81 (6.8)11 (6.5)1

Disseminated cancer, n (%)10 (0.7)8 (0.7)2 (1.2)0.3
Paraplegia, n (%)8 (0.6)7 (0.6)1 (0.6)1
Open wound/wound infection, n (%)213 (15.6)143 (12)70 (41.2)<0.00001
Steroid use, n (%)44 (3.2)35 (2.9)9 (5.3)0.1
>10% weight loss in 6 months, n (%)24 (1.8)12 (1)12 (7.1)<0.00001
Bleeding diathesis, n (%)349 (25.5)282 (23.6)67 (39.4)<0.00001
Transfusion >4U of PRBC 72 hrs pre op, n (%)12 (0.9)8 (0.7)4 (2.4)0.051
Chemotherapy for malignancy, n (%)9 (0.7)7 (0.6)2 (1.2)0.3
Radiotherapy for malignancy, n (%)4 (0.3)2 (0.2)2 (1.2)0.07
Prior operation in last 30 days, n (%)60 (4.4)39 (3.3)21 (12.4)<0.00001


Back to 2016 Karmody Posters
 
© 2024 Society for Clinical Vascular Surgery . All Rights Reserved. Privacy Policy.